{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:20:33Z","timestamp":1793578833337,"version":"4.5.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamaneurol.2021.3671","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:37:08Z","timestamp":1634751428000},"page":"1471","source":"Crossref","is-referenced-by-count":632,"title":["Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum"],"prefix":"10.1001","volume":"78","author":[{"given":"Andr\u00e9a L.","family":"Benedet","sequence":"first","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mil\u00e0-Alom\u00e0","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Vrillon","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Universit\u00e9 de Paris, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale U1144 Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"},{"name":"Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique H\u00f4pitaux de Paris Nord H\u00f4pital Lariboisi\u00e8re Fernand-Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"National Institute for Health Research Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley National Health Service Foundation, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza","family":"Lussier","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hourregue","sequence":"additional","affiliation":[{"name":"Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique H\u00f4pitaux de Paris Nord H\u00f4pital Lariboisi\u00e8re Fernand-Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale U1144 Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"},{"name":"Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique H\u00f4pitaux de Paris Nord H\u00f4pital Lariboisi\u00e8re Fernand-Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[{"name":"Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique H\u00f4pitaux de Paris Nord H\u00f4pital Lariboisi\u00e8re Fernand-Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pallen","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"Poltronetti","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salvad\u00f3","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Shekari","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Operto","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Bioingenier\u00eda, Biomateriales y Nanomedicina, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguillon","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Fauria","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[{"name":"Roche Diagnostics GmbH, Penzberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Suridjan","sequence":"additional","affiliation":[{"name":"Roche Diagnostics International Ltd, Rotkreuz, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo R.","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate Program in Biological Sciences: Biochemistry (PPGBioq) and Phamacology and Therapeutics (PPGFT), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom"},{"name":"UK Dementia Research Institute at University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale U1144 Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"},{"name":"Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique H\u00f4pitaux de Paris Nord H\u00f4pital Lariboisi\u00e8re Fernand-Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[{"name":"Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada"},{"name":"Montreal Neurological Institute, Montreal, Quebec, Canada"},{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[{"name":"Barcelona\u00dfeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"},{"name":"Servei de Neurologia, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Beteta","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ca\u00f1as","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Deulofeu","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cumplido","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dominguez","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Emilio","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Falcon","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Fuentes","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hernandez","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Huesa","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Huguet","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marne","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mench\u00f3n","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Operto","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Polo","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pradas","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Soteras","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vilanova","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vilor-Tejedor","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Gaubert","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lilamand","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Hugon","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Indart","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Fayel","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Gmiz","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Francisque","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Meauzoone","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Martinet","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Tence","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Chamoun","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tissot","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Bezgin","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilaine","family":"Gagnon","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Stevensson","sequence":"additional","affiliation":[{"name":"for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer\u2019s and Families (ALFA) study, and BioCogBank Paris Lariboisi\u00e8re cohort"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi210065r1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma p-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia.","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"noi210065r2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi210065r3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration.","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"noi210065r4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"5","key":"noi210065r5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology.","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"8","key":"noi210065r6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders.","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"noi210065r7","doi-asserted-by":"publisher","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma \u00df-amyloid in Alzheimer\u2019s disease and vascular disease.","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"noi210065r8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.v84.5","article-title":"Plasma amyloid as prescreener for the earliest Alzheimer pathological changes.","volume":"84","author":"Verberk","year":"2018","journal-title":"Ann Neurol"},{"issue":"7","key":"noi210065r9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.v17.7","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease.","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"7691","key":"noi210065r10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u00df biomarkers for Alzheimer\u2019s disease.","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"17","key":"noi210065r11","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u00df-amyloid 42\/40 predicts current and future brain amyloidosis.","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"noi210065r12","first-page":"434","article-title":"Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70.","volume":"144","author":"Keshavan","year":"2021","journal-title":"Brain"},{"issue":"3","key":"noi210065r13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions.","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"issue":"4","key":"noi210065r14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","article-title":"Astrocytes in Alzheimer\u2019s disease.","volume":"7","author":"Verkhratsky","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"2","key":"noi210065r15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","article-title":"Astrocyte biomarkers in Alzheimer\u2019s disease.","volume":"25","author":"Carter","year":"2019","journal-title":"Trends Mol Med"},{"issue":"1","key":"noi210065r16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease.","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"24","key":"noi210065r17","doi-asserted-by":"publisher","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis.","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"noi210065r18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"In vivo quantification of neurofibrillary tangles with [18F]MK-6240.","volume":"10","author":"Pascoal","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"noi210065r19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","article-title":"The ALFA Project: a research platform to identify early pathophysiological features of Alzheimer\u2019s disease.","volume":"2","author":"Molinuevo","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"noi210065r20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3233\/JAD-2011-111007","article-title":"CSF A\u00df1-42 levels and glucose metabolism in Alzheimer\u2019s disease.","volume":"27","author":"Dumurgier","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"noi210065r21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5","key":"noi210065r22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"noi210065r23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13195-021-00863-y","article-title":"Cognitively unimpaired individuals with a low burden of A\u00df pathology have a distinct CSF biomarker profile.","volume":"13","author":"Mil\u00e0-Alom\u00e0","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"noi210065r24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment.","volume":"67","author":"Oeckl","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"noi210065r25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology.","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"noi210065r26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-200755","article-title":"Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage.","volume":"78","author":"Asken","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"noi210065r27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease.","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"2","key":"noi210065r28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.","volume":"136","author":"Ishiki","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"noi210065r29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000050753","article-title":"The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer\u2019s disease patients and correlates with severity of dementia.","volume":"46","author":"Fukuyama","year":"2001","journal-title":"Eur Neurol"},{"issue":"3","key":"noi210065r30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u2019s disease and Creutzfeldt-Jakob disease.","volume":"17","author":"Jesse","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"noi210065r31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"noi210065r32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/jnc.v155.4","article-title":"Amyloid-\u00df oligomers in cellular models of Alzheimer\u2019s disease.","volume":"155","author":"Fontana","year":"2020","journal-title":"J Neurochem"},{"issue":"1","key":"noi210065r33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","article-title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.","volume":"53","author":"Carter","year":"2012","journal-title":"J Nucl Med"},{"issue":"1","key":"noi210065r34","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1038\/srep16404","article-title":"Early astrocytosis in autosomal dominant Alzheimer\u2019s disease measured in vivo by multi-tracer positron emission tomography.","volume":"5","author":"Sch\u00f6ll","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"noi210065r35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-015-3047-0","article-title":"Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.","volume":"42","author":"Rodriguez-Vieitez","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"noi210065r36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","article-title":"Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.","volume":"85","author":"Alcolea","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"noi210065r37","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/alz.v16.10","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum.","volume":"16","author":"Mil\u00e0-Alom\u00e0","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"noi210065r38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"noi210065r39","year":"2009","journal-title":"Front Neurol Neurosci"},{"issue":"2","key":"noi210065r40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A\u00df42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res"},{"issue":"4","key":"noi210065r41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"6","key":"noi210065r42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1440-1819.1998.tb02706.x","article-title":"A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer\u2019s disease, normal controls and non-Alzheimer neuropsychiatric diseases.","volume":"52","author":"Muramori","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"noi210065r43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-4886(95)90022-5","article-title":"Early association of reactive astrocytes with senile plaques in Alzheimer\u2019s disease.","volume":"132","author":"Pike","year":"1995","journal-title":"Exp Neurol"},{"issue":"3","key":"noi210065r44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration.","volume":"77","author":"Benussi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"noi210065r45","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102870","article-title":"A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: a systematic review and meta-analysis.","volume":"51","author":"Sun","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"noi210065r46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","article-title":"Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.","volume":"59","author":"Papa","year":"2012","journal-title":"Ann Emerg Med"},{"issue":"5","key":"noi210065r47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury.","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1-2","key":"noi210065r48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jns.2005.09.007","article-title":"Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.","volume":"240","author":"Nyl\u00e9n","year":"2006","journal-title":"J Neurol Sci"},{"issue":"5","key":"noi210065r49","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1161\/STROKEAHA.106.478362","article-title":"Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage.","volume":"38","author":"Nyl\u00e9n","year":"2007","journal-title":"Stroke"},{"issue":"12","key":"noi210065r50","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.resuscitation.2014.09.007","article-title":"Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome.","volume":"85","author":"Larsson","year":"2014","journal-title":"Resuscitation"},{"issue":"3","key":"noi210065r51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"noi210065r52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/CS20171634","article-title":"The pericyte-glia interface at the blood-brain barrier.","volume":"132","author":"Giannoni","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"147","key":"noi210065r53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u00df.","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"issue":"7560","key":"noi210065r54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels.","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"1","key":"noi210065r55","article-title":"Effects of pre-analytical procedures on blood biomarkers for Alzheimer\u2019s pathophysiology, glial activation, and neurodegeneration.","volume":"13","author":"Ashton","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"noi210065r56","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fneur.2019.00280","article-title":"Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?","volume":"10","author":"Abdelhak","year":"2019","journal-title":"Front Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2784931\/jamaneurology_benedet_2021_oi_210065_1638811676.54317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:21:28Z","timestamp":1639048888000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2784931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3671","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}